Antitumor activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone.

Diletta Bianchini, David Lorente, Alejo Rodriguez-Vida, Aurelius Omlin, Carmel Jo Pezaro, Roberta Ferraldeschi, Andrea Zivi, Gerhardt Attard, Simon Chowdhury, Johann S De Bono

Research output: Contribution to journalArticleResearchpeer-review

182 Citations (Scopus)
Original languageEnglish
Pages (from-to)78-84
Number of pages7
JournalEuropean Journal of Cancer
Issue number1
Publication statusPublished - 2014
Externally publishedYes

Cite this